However, GSDMD as a pyroptosis executive protein is more highly expressed in non-small cell lung cancer (NSCLC) than para-cancer tissues, and knockdown of GSDMD can attenuate the EGFR/Akt signaling pathway to restrict tumor growth in NSCLC (25). Here, EGFR is linked to non-small cell lung carcinoma.